Children with segmental neurofibromatosis type 1 are at increased risk for academic and cognitive difficulties

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pediatric Neurology online

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JPN-2010-0411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The neurofibromatoses

  2010cited by this paper
• Unexplained autism is frequently associated with low-level mosaic aneuploidy

  2007cited by this paper
• Academic Impairment is the Most Frequent Complication of Neurofibromatosis Type-1 (NF1) in Children

  2006cited by this paper
• The nature and frequency of cognitive deficits in children with neurofibromatosis type 1

  2005cited by this paper
• X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.

  2004cited by this paper
• Neurocognitive dysfunction in children with neurofibromatosis type 1

  2003cited by this paper
• Segmental neurofibromatosis in childhood

  2003influential reference
• Visual–spatial performance deficits in children with neurofibromatosis type‐1

  2003cited by this paper
• Cortical morphology associated with language function in neurofibromatosis, type I.

  2003cited by this paper
• Review Article : Cognitive Deficits in Neurofibromatosis 1

  2002cited by this paper
• Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1

  2002cited by this paper
• Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons.

  2001cited by this paper
• The clinical and diagnostic implications mosaicism in the neurofibromatoses

  2001influential reference
• The Association of Neurofibromatosis Type 1 and Attention Deficit Hyperactivity Disorder

  2000cited by this paper
• How Children With Neurofibromatosis Type 1 Differ From "Typical" Learning Disabled Clinic Attenders: Nonverbal Learning Disabilities Revisited

  2000cited by this paper
• Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children

  2000cited by this paper
• Cognitive impairment in neurofibromatosis type 1.

  1999cited by this paper
• The neurofibromatoses. An overview

  1999cited by this paper
• Segmental neurofibromatosis: case reports and review.

  1997cited by this paper
• Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.

  1997cited by this paper
• Children and Adolescents with Neurofibromatosis 1: A Behavioral Phenotype

  1996cited by this paper
• Intellectual impairment in neurofibromatosis 1.

  1996cited by this paper
• Neurofibromin Expression and Astrogliosis in Neurofibromatosis (Type 1) Brains

  1995cited by this paper
• Segmental neurofibromatosis: is it uncommon or underdiagnosed?

  1995cited by this paper
• COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

  1995cited by this paper
• More on the frequency of segmental neurofibromatosis.

  1995cited by this paper
• Neurofibromatosis type 1: the cognitive phenotype.

  1994cited by this paper
• Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1)

  1993cited by this paper
• Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development

  1992cited by this paper
• The diagnosis of neurofibromatosis-1 in the child under the age of 6 years.

  1989cited by this paper
• Neurofibromatosis: clinical heterogeneity.

  1982cited by this paper

• Post-Compulsory Education in Teenagers and Young Adults Treated for Brain Tumors in Childhood: A Swedish Nationwide Registry-Based Study

  2022cites this paper